These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18473704)

  • 1. Antidepressant therapy in post-stroke depression.
    Starkstein SE; Mizrahi R; Power BD
    Expert Opin Pharmacother; 2008 Jun; 9(8):1291-8. PubMed ID: 18473704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depressive disorders in patients after stroke].
    Gusev EI; Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 22():10-5. PubMed ID: 19431241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive disorders in stroke patients.
    Gusev EI; Bogolepova AN
    Neurosci Behav Physiol; 2009 Sep; 39(7):639-43. PubMed ID: 19621267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic treatment of poststroke depression: a systematic review of the literature.
    Van de Meent H; Geurts AC; Van Limbeek J
    Top Stroke Rehabil; 2003; 10(1):79-92. PubMed ID: 12970833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poststroke depression: prevalence, diagnosis, treatment, and disease progression.
    Robinson RG
    Biol Psychiatry; 2003 Aug; 54(3):376-87. PubMed ID: 12893112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Stroke Depression in Older Adults: An Overview.
    Masuccio FG; Grange E; Di Giovanni R; Rolla M; Solaro CM
    Drugs Aging; 2024 Apr; 41(4):303-318. PubMed ID: 38396311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Stroke Depression: A Review.
    Robinson RG; Jorge RE
    Am J Psychiatry; 2016 Mar; 173(3):221-31. PubMed ID: 26684921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives.
    Turner-Stokes L; Hassan N
    Clin Rehabil; 2002 May; 16(3):248-60. PubMed ID: 12017512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
    Karaiskos D; Tzavellas E; Spengos K; Vassilopoulou S; Paparrigopoulos T
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):349-53. PubMed ID: 23037649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis.
    Chen Y; Guo JJ; Zhan S; Patel NC
    Ann Pharmacother; 2006 Dec; 40(12):2115-22. PubMed ID: 17119102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, acceptability, and tolerability of antidepressant treatments for patients with post-stroke depression: a network meta-analysis.
    Qin B; Chen H; Gao W; Zhao LB; Zhao MJ; Qin HX; Chen W; Chen L; Yang MX
    Braz J Med Biol Res; 2018; 51(7):e7218. PubMed ID: 29742266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients.
    Oslin DW; Streim JE; Katz IR; Smith BD; DiFilippo SD; Ten Have TR; Cooper T
    Am J Geriatr Psychiatry; 2000; 8(2):141-9. PubMed ID: 10804075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-stroke depression.
    Lenzi GL; Altieri M; Maestrini I
    Rev Neurol (Paris); 2008 Oct; 164(10):837-40. PubMed ID: 18771785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological management of post-stroke depression.
    Castilla-Guerra L; Fernandez Moreno MDC; Esparrago-Llorca G; Colmenero-Camacho MA
    Expert Rev Neurother; 2020 Feb; 20(2):157-166. PubMed ID: 31860359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Post-stroke depression: recognition and treatment interventions].
    Arseniou S; Arvaniti A; Samakouri M
    Psychiatriki; 2011; 22(3):240-8. PubMed ID: 21971199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression.
    Nobler MS; Roose SP; Prohovnik I; Moeller JR; Louie J; Van Heertum RL; Sackeim HA
    Am J Geriatr Psychiatry; 2000; 8(4):289-96. PubMed ID: 11069268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sertraline for post-stroke depression: A systematic review protocol of randomized controlled trial.
    Bai ZF; Wang LY
    Medicine (Baltimore); 2019 Apr; 98(16):e15299. PubMed ID: 31008979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of poststroke depression: does prophylactic pharmacotherapy work?
    Salter KL; Foley NC; Zhu L; Jutai JW; Teasell RW
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1243-51. PubMed ID: 22554569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
    Krishnan KR; Doraiswamy PM; Clary CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):347-61. PubMed ID: 11294481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline.
    Turner-Stokes L; Hassan N; Pierce K; Clegg F
    Clin Rehabil; 2002 May; 16(3):261-8. PubMed ID: 12017513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.